The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market.

The surge in diseases is spurring demand for constructive treatment solutions, which is expected to boost the sales of injectable pharmaceutical companies. Generic injectables firms are also growing significantly due to the extensive use of generic injectables in the treatment of a wide range of chronic diseases while providing the same efficacy and safety as the reference injectables.

Commercial dose injectables companies in contract marketing can strategically launch and position the product in the market and modify the marketing management strategies.

Discover the top commercial dose injectables companies in contract marketing

Pharmaceutical Technology has listed the leading commercial dose injectables companies in contract marketing based on its intel, insights, and decades of experience in the sector.

The list includes providers of various services and solutions, including:

  • Hypodermal injection needles
  • Cartridge-based injections
  • Solubiliser and emulsifier agents
  • Type II premium injection vials, and ampoules
  • Implanters
  • Dry injections
  • Digital marketing strategies integrated with commercial strategies
  • Multi-channel marketing and closed-loop marketing
  • Patient and customer surveys
  • Customisation and personalisation
  • Business processes automation
  • Medical communications
  • Reputation and risk management
  • Brand naming and development, and
  • Commercial recruiting solutions

The information contained within the download document is intended for manufacturers, suppliers, distributors, pharmaceutical executives, medical representatives, distributors, pharmacists, business development managers, retail salesmen, sales managers, product marketing managers, and any other individual involved in drug injectables marketing.

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Factors driving the demand for injectables

Rapid absorption, faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are driving the demand for injectable commercial doses. Injectable pharmaceutical companies are gaining traction on products and applications such as monoclonal antibodies, large molecule injectable drugs, and drugs treating infectious diseases. Factors such as the growing prevalence of chronic diseases, shorter and cheaper research and development (R&D) cycles of generic injectables, growing focus on the treatment of rare diseases, and an increase in the preference for generic injectables are boosting the growth of the generic injectables companies in the global market.